AW
RLAY icon

Avion Wealth’s Relay Therapeutics RLAY Stock Holding History

Avion Wealth’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Hold
136
– – ﹤0.01% 1113
2026
Q1 		$1K Hold
136
– – ﹤0.01% 1121
2025
Q4 		$1K Hold
136
– – ﹤0.01% 1120
2025
Q3 		$0 Hold
136
– – ﹤0.01% 1491
2025
Q2 		$0 Buy
+136
New +$405 ﹤0.01% 1543

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Avion Wealth's RLAY Position: Q2 2026 in Review

Avion Wealth held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 136 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Avion Wealth first reported a position in RLAY in Q2 2025 and has held it in 5 quarters since. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Avion Wealth held 136 shares of Relay Therapeutics worth $2K as of Q2 2026.
  • Avion Wealth left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1113 holding.
  • Avion Wealth first reported a position in Relay Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.